GLP-1s reduced mortality and complications from cardiovascular events, according to a study published Aug. 22 in Diabetes, Obesity and Metabolism: A Journal of Pharmacology and Therapeutics.
Cardiology
GLP-1s reduced mortality and complications from cardiovascular events, according to a study published Aug. 22 in Diabetes, Obesity and Metabolism: A Journal of Pharmacology and Therapeutics.
Cardiology leaders are familiar with the common challenges across healthcare with staffing, pay issues and patient access being among the most pressing. But recently leaders are highlighting other areas that are contributing to the complex network of challenges.
High-poverty rural regions in the Southern U.S. have the highest cardiovascular disease-associated death rate, according to a report published Aug. 16 in the Journal of Rural Health.
Catheter-based, radiofrequency renal denervation is a cost-effective solution for patients with hypertension, according to a study published Aug. 13 in the Journal of the Society for Cardiovascular Angiography & Interventions.
Advertisement
The FDA approved a label change for Abbott's HeartMate 3 heart pump, eliminating aspirin use from patient treatment plans.
Women with postoperative atrial fibrillation have a higher risk of mortality than men, according to a study published Aug. 21 in JAMA Network Open.
Leaders from four cardiology hospitals that were ranked among the best by U.S. News & World Report shared with Becker's what they would change about cardiology care.
From traveling to space to running for mayor, here are 12 cardiologists making headlines:
Researchers from New York City-based NYU Langone Health have created a scoring tool to help physicians identify patients at risk for cardiovascular events.